Abbott Laboratories (NYSE:ABT) is one of Goldman Sachs top healthcare stocks. On March 10, Abbott Laboratories (NYSE:ABT) ...

Abbott, the global healthcare company, today announced the launch of XIENCE Skypoint in India. This is Abbott’s most advanced ...

Abbott launches XIENCE Skypoint drug-eluting stent in India, designed to treat complex heart artery blockages and support ...

Abbott launches ICRAS Tool to enable early identification of diabetes related heart and kidney risks: Our Bureau, Bengaluru Thursday, March 12, 2026, 17:15 Hrs [IST] Abbott has an ...

GHAZIABAD, India, Jan 23 (Reuters) - Indian drugmaker Abbott Healthcare's supply chain is being scrutinised as part of a wider investigation into the alleged misuse of its codeine-based cough syrup ...

The new device, XIENCE Skypoint, is designed to be more flexible, easier to guide through the heart's arteries, including ...

BENGALURU, Aug 9 (Reuters) - Abbott India (ABOT.NS), opens new tab, the Indian arm of U.S. healthcare firm Abbott Laboratories (ABT.N), opens new tab, reported a 41% rise in its first-quarter profit ...

Abbott has teamed up with Novo Nordisk India to launch Extensior, a second brand of the diabetes drug semaglutide, aiming to expand access to GLP-1 therapy in India.

The Nifty fell 1.6% amid broad-based selling triggered by the Iran-Israel conflict, with financials, auto and energy stocks ...